OBJECTIVES: To evaluate the feasibility and outcome of noninvasive positive pressure ventilation (NPPV) in daily clinical practice. DESIGN: Observational retrospective cohort study. SETTING: Pediatric intensive care unit in a university hospital. PATIENTS: : Patients treated by NPPV, regardless of the indication, during five consecutive years (2000-2004). MEASUREMENTS AND RESULTS: A total of 114 patients were included, and 83 of the 114 patients (77%) were successfully treated by NPPV without intubation (NPPV success group). The success rate of NPPV was significantly lower (22%) in the patients with acute respiratory distress syndrome (p < .05) than in the other patients. The Pediatric Risk of Mortality II (p = .003) and Pediatric Logistic Organ Dysfunction scores (p = .002) at admission were significantly higher in patients who were unsuccessfully treated with NPPV (NPPV failure group). Baseline values of Pco2, pulse oximetry, and respiratory rate did not differ between the two groups. A significant decrease in Pco2 and respiratory rate within the first 2 hrs of NPPV was observed in the NPPV success group. Multivariate analysis showed that a diagnosis of acute respiratory distress syndrome (odds ratio, 76.8; 95% confidence interval, 4.4-1342; p = .003) and a high Pediatric Logistic Organ Dysfunction score (odds ratio, 1.09; 95% confidence interval, 1.01-1.17; p = .01) were independent predictive factors for NPPV failure. A total of 11 patients (9.6%), all belonging to the NPPV failure group, died during the study. CONCLUSIONS: This study demonstrates the feasibility and efficacy of NPPV in the daily practice of a pediatric intensive care unit. This ventilatory support could be proposed as a first-line treatment in children with acute respiratory distress, except in those with a diagnosis of acute respiratory distress syndrome.
OBJECTIVES: To evaluate the feasibility and outcome of noninvasive positive pressure ventilation (NPPV) in daily clinical practice. DESIGN: Observational retrospective cohort study. SETTING: Pediatric intensive care unit in a university hospital. PATIENTS: : Patients treated by NPPV, regardless of the indication, during five consecutive years (2000-2004). MEASUREMENTS AND RESULTS: A total of 114 patients were included, and 83 of the 114 patients (77%) were successfully treated by NPPV without intubation (NPPV success group). The success rate of NPPV was significantly lower (22%) in the patients with acute respiratory distress syndrome (p < .05) than in the other patients. The Pediatric Risk of Mortality II (p = .003) and Pediatric Logistic Organ Dysfunction scores (p = .002) at admission were significantly higher in patients who were unsuccessfully treated with NPPV (NPPV failure group). Baseline values of Pco2, pulse oximetry, and respiratory rate did not differ between the two groups. A significant decrease in Pco2 and respiratory rate within the first 2 hrs of NPPV was observed in the NPPV success group. Multivariate analysis showed that a diagnosis of acute respiratory distress syndrome (odds ratio, 76.8; 95% confidence interval, 4.4-1342; p = .003) and a high Pediatric Logistic Organ Dysfunction score (odds ratio, 1.09; 95% confidence interval, 1.01-1.17; p = .01) were independent predictive factors for NPPV failure. A total of 11 patients (9.6%), all belonging to the NPPV failure group, died during the study. CONCLUSIONS: This study demonstrates the feasibility and efficacy of NPPV in the daily practice of a pediatric intensive care unit. This ventilatory support could be proposed as a first-line treatment in children with acute respiratory distress, except in those with a diagnosis of acute respiratory distress syndrome.
Authors: Marco Piastra; Daniele De Luca; Laura Marzano; Eleonora Stival; Orazio Genovese; Domenico Pietrini; Giorgio Conti Journal: Intensive Care Med Date: 2011-07-14 Impact factor: 17.440
Authors: J Walk; P Dinga; C Banda; T Msiska; E Chitsamba; N Chiwayula; N Lufesi; R Mlotha-Mitole; A Costello; A Phiri; T Colbourn; E D McCollum; H J Lang Journal: Paediatr Int Child Health Date: 2014-11-30 Impact factor: 1.990
Authors: Christopher S James; Christopher P J Hallewell; Dominique P L James; Angie Wade; Quen Q Mok Journal: Intensive Care Med Date: 2011-10-08 Impact factor: 17.440
Authors: Asavari Kamerkar; Justin Hotz; Rica Morzov; Christopher J L Newth; Patrick A Ross; Robinder G Khemani Journal: J Pediatr Date: 2017-03-30 Impact factor: 4.406
Authors: Juan I Muñoz-Bonet; Eva M Flor-Macián; Patricia M Roselló; Mari C Llopis; Alicia Lizondo; José L López-Prats; Juan Brines Journal: World J Pediatr Date: 2010-06-12 Impact factor: 2.764
Authors: Juan Mayordomo-Colunga; Martí Pons; Yolanda López; M José Solana; Corsino Rey; Pablo Martínez-Camblor; Antonio Rodríguez-Núñez; Jesús López-Herce; Alberto Medina; Clara Abadesso; M Angeles García-Teresa; Mirella Gáboli; Milagros García-López; María González-Sánchez; Paula Madurga-Revilla; Amelia González-Calvar; Eider Oñate Journal: Intensive Care Med Date: 2013-03-27 Impact factor: 17.440
Authors: Juan Mayordomo-Colunga; Alberto Medina; Corsino Rey; Juan José Díaz; Andrés Concha; Marta Los Arcos; Sergio Menéndez Journal: Intensive Care Med Date: 2008-11-04 Impact factor: 17.440
Authors: Juan Mayordomo-Colunga; Alberto Medina; Corsino Rey; Andrés Concha; Sergio Menéndez; Marta Los Arcos; Irene García Journal: BMC Pediatr Date: 2010-05-05 Impact factor: 2.125